Astellas

FDA adds liver injury warning for Veozah
Beckers Hospital Review
Wed, 12/18/24 - 11:26 am
FDA
black box
Astellas
Veozah
liver injury
hot flashes
menopause
How Astellas juggles the moving parts of cancer precision medicine development
Pharma Voice
Thu, 12/5/24 - 11:05 am
Astellas
Vyloy
gastric cancer
precision medicine
Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan
Tip Ranks
Tue, 11/19/24 - 11:13 am
Astellas
Apellis
FDA
geographic atrophy
Izervay
Syfovre
Essa abandons sole clinical-stage drug after falling short against Xtandi in phase 2 trial
Fierce Biotech
Sun, 11/3/24 - 10:17 pm
Essa Pharma
prostate cancer
masofaniten
Xtandi
Astellas
Pfizer
Astellas doesn't see eye to eye with Europe on geographic atrophy drug Izervay
Fierce Pharma
Mon, 10/28/24 - 06:12 pm
Astellas
Izervay
Apellis
Syfovre
geographic atrophy
Europe
Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy
Fierce Pharma
Sun, 10/20/24 - 10:22 pm
Astellas
FDA
Vyloy
gastric cancer
Astella’s iota receives FDA go-ahead for bladder implant trial
Clinical Trials Arena
Mon, 10/14/24 - 11:16 pm
Astellas
iota Biosciences
FDA
Medtech
underactive bladder
clinical trials
Astellas licenses AviadoBio’s dementia gene therapy candidate
Biopharma Reporter
Fri, 10/11/24 - 09:29 am
Astellas
AviadoBio
dementia
gene therapy
Astellas unveils new Japan site for cell therapy research arm Universal Cells, transferring 12 roles overseas
Fierce Biotech
Wed, 10/9/24 - 09:07 pm
Astellas
Japan
cell therapy
Universal Cell
Astellas places $2bn+ bet on AviadoBio dementia gene therapy
Pharmaphorum
Tue, 10/8/24 - 09:44 am
Astellas
gene therapy
AviadoBio
frontotemporal dementia
J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study
Fierce Pharma
Wed, 10/2/24 - 09:50 pm
JNJ
Erleada
prostate cancer
Astellas
Pfizer
Xtandi
Astellas brings its first digital health product to US
Pharmaphorum
Fri, 09/20/24 - 10:20 am
Astellas
digital health
heart failure
ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC
Clinical Trials Arena
Tue, 09/17/24 - 11:13 am
Eli Lilly
ESMO
lutetium zadavotide guraxetan
Astellas
Janssen
metastatic castration-resistant prostate cancer
Astellas unveils Massachusetts lab that will be shared with biotechs, academia researchers
Fierce Biotech
Thu, 09/5/24 - 10:37 pm
Astellas
Massachusetts
biotech
SakuLab
R&D
Japan's Astellas says employee indicted by China's prosecutors
Reuters
Wed, 08/21/24 - 11:17 am
China
Astellas
legal
espionage
Astellas' gastric cancer therapy gets UK regulator's nod
Reuters
Wed, 08/14/24 - 11:19 am
Astellas
UK
gastric cancer
monoclonal antibodies
Vyloy
3 Big Pharma cancer drugs facing inflation penalties
Pharma Voice
Wed, 07/31/24 - 10:27 am
inflation
Inflation Reduction Act
drug pricing
Abecma
Breyanzi
Bristol Myers Squibb
Pfizer
Adcetris
Astellas
Padcev
cancer
European Commission approves Astellas’ drug for expanded prostate cancer Treatment
Outsourcing Pharma
Thu, 04/25/24 - 05:59 pm
Astellas
Xtandi
Europe
prostate cancer
Pharmas form joint venture to jumpstart Japanese drug research
BioPharma Dive
Mon, 04/22/24 - 11:29 am
Japan
R&D
Takeda
Astellas
Sumitomo Mitsui Banking
Invenra, Astellas sign bispecific antibody discovery agreement
Pharmaceutical Business Review
Wed, 04/10/24 - 09:50 am
Astellas
Invenra
B-Body
bispecific antibodies
R&D

Pages